ApplicationsExplore key insights in your field

In FocusDiscover latest updates & stories

  • QIAGEN and Illumina partner to broaden the availability and use of NGS-based in vitro diagnostic (IVD) kits. Read the full press release here.
  • At OEM by QIAGEN, we are committed to developing high-quality, customized solutions for your innovative business. You can improve your time to market and make your innovative product a commercial reality. From a specific component to an entire workflow - we offer our expertise as a long-term trusted partner, with full confidentiality, every step of the way.
  • Despite great progress made by scientists and physicians dedicated to cancer research, a lot of increasingly complex questions remain to be answered to discover new ways to prevent, detect and treat cancer. Visit our new website – advance your cancer research, accelerate your journey to insights and help to conquer cancer.
  • Maximize your miRNA sequencing and qPCR success from liquid biopsy samples, including blood, serum/plasma, urine, CSF and exosomes. Find out how, plus get helpful tips and valuable advice in our guidelines for profiling biofluid miRNAs booklet. Download now.
  • A new study reinforces the utility of liquid biopsy to identify clinically actionable mutations and guide clinical trial enrollment for patients with advanced cancer. Download your copy of the paper.
  • QIAGEN and Illumina partner to broaden the availability and use of NGS-based in vitro diagnostic (IVD) kits. Read the full press release here.
  • At OEM by QIAGEN, we are committed to developing high-quality, customized solutions for your innovative business. You can improve your time to market and make your innovative product a commercial reality. From a specific component to an entire workflow - we offer our expertise as a long-term trusted partner, with full confidentiality, every step of the way.
  • Despite great progress made by scientists and physicians dedicated to cancer research, a lot of increasingly complex questions remain to be answered to discover new ways to prevent, detect and treat cancer. Visit our new website – advance your cancer research, accelerate your journey to insights and help to conquer cancer.
  • Maximize your miRNA sequencing and qPCR success from liquid biopsy samples, including blood, serum/plasma, urine, CSF and exosomes. Find out how, plus get helpful tips and valuable advice in our guidelines for profiling biofluid miRNAs booklet. Download now.
  • A new study reinforces the utility of liquid biopsy to identify clinically actionable mutations and guide clinical trial enrollment for patients with advanced cancer. Download your copy of the paper.

Featured ProductsSee this week's favorites

Learning HubAccess our expansive knowledge base

X
Cookies help us improve your website experience.
By using our website, you agree to our use of cookies.
Confirm